Q3 2016 13F Holders as of 9/30/2016
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
183M
-
Number of holders
-
86
-
Total 13F shares, excl. options
-
44.9M
-
Shares change
-
+4.23M
-
Total reported value, excl. options
-
$774M
-
Value change
-
+$71.9M
-
Put/Call ratio
-
0.59
-
Number of buys
-
47
-
Number of sells
-
-35
-
Price
-
$17.23
Significant Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) as of Q3 2016
112 filings reported holding HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share as of Q3 2016.
HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) has 86 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44.9M shares
of 183M outstanding shares and own 24.51% of the company stock.
Largest 10 shareholders include FRANKLIN RESOURCES INC (7.74M shares), FMR LLC (5.85M shares), JANUS CAPITAL MANAGEMENT LLC (4.03M shares), Partner Fund Management, L.P. (3.39M shares), BAKER BROS. ADVISORS LP (2.86M shares), Broadfin Capital, LLC (2.85M shares), Invesco Ltd. (2.77M shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (2.7M shares), Cormorant Asset Management, LLC (1.77M shares), and VANGUARD GROUP INC (1.31M shares).
This table shows the top 86 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.